Nisa Investment Advisors
JAZZ icon

Nisa Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nisa Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.94K Buy
42
+4
+11% +$699 ﹤0.01% 2320
2025
Q4 		$6.46K Buy
38
+11
+41% +$1.69K ﹤0.01% 2385
2025
Q3 		$3.56K Hold
27
– – ﹤0.01% 2512
2025
Q2 		$2.87K Sell
27
-203
-88% -$22.1K ﹤0.01% 2539
2025
Q1 		$28.6K Hold
230
– – ﹤0.01% 1754
2024
Q4 		$28.3K Sell
230
-15
-6% -$1.77K ﹤0.01% 1831
2024
Q3 		$27.3K Sell
245
-4
-2% -$438 ﹤0.01% 1809
2024
Q2 		$26.6K Sell
249
-14,037
-98% -$1.54M ﹤0.01% 1843
2024
Q1 		$1.72M Buy
14,286
+5,126
+56% +$628K 0.01% 732
2023
Q4 		$1.13M Buy
9,160
+9,098
+14,674% +$1.14M 0.01% 818
2023
Q3 		$8.03K Sell
62
-15
-19% -$2K ﹤0.01% 2220
2023
Q2 		$9.55K Sell
77
-9,994
-99% -$1.34M ﹤0.01% 2266
2023
Q1 		$1.47M Hold
10,071
– – 0.01% 742
2022
Q4 		$1.6M Buy
10,071
+10,000
+14,085% +$1.47M 0.01% 792
2022
Q3 		$9K Sell
71
-1,129
-94% -$172K ﹤0.01% 2211
2022
Q2 		$187K Hold
1,200
– – ﹤0.01% 1327
2022
Q1 		$187K Sell
1,200
-2,471
-67% -$359K ﹤0.01% 1405
2021
Q4 		$510K Sell
3,671
-34,439
-90% -$4.53M ﹤0.01% 1007
2021
Q3 		$4.96K Sell
38,110
-20,636
-35% -$3.12M 0.03% 441
2021
Q2 		$10.4K Buy
58,746
+36,315
+162% +$6.29M 0.07% 270
2021
Q1 		$3.69K Sell
22,431
-27,139
-55% -$4.47M 0.02% 536
2020
Q4 		$8.18M Buy
49,570
+32,487
+190% +$4.84M 0.05% 310
2020
Q3 		$2.44M Sell
17,083
-8,541
-33% -$1.06M 0.02% 552
2020
Q2 		$2.83M Sell
25,624
-3,296
-11% -$364K 0.03% 489
2020
Q1 		$2.88M Buy
28,920
+14,448
+100% +$1.87M 0.03% 429
2019
Q4 		$2.16M Sell
14,472
-8,906
-38% -$1.21M 0.02% 616
2019
Q3 		$3M Buy
23,378
+10,606
+83% +$1.42M 0.03% 513
2019
Q2 		$1.82M Sell
12,772
-8,442
-40% -$1.13M 0.02% 668
2019
Q1 		$3.03M Buy
21,214
+7,018
+49% +$915K 0.03% 493
2018
Q4 		$1.76M Sell
14,196
-8,959
-39% -$1.33M 0.02% 602
2018
Q3 		$3.89M Buy
23,155
+17,955
+345% +$3.09M 0.04% 435
2018
Q2 		$896K Hold
5,200
– – 0.01% 876
2018
Q1 		$785K Sell
5,200
-1,000
-16% -$147K 0.01% 899
2017
Q4 		$835K Sell
6,200
-200
-3% -$27.7K 0.01% 887
2017
Q3 		$936K Buy
6,400
+6,200
+3,100% +$938K 0.01% 840
2017
Q2 		$31K Sell
200
-800
-80% -$122K ﹤0.01% 1439
2017
Q1 		$145K Hold
1,000
– – ﹤0.01% 1304
2016
Q4 		$109K Sell
1,000
-10,268
-91% -$1.14M ﹤0.01% 1335
2016
Q3 		$1.37M Buy
11,268
+544
+5% +$73.3K 0.02% 688
2016
Q2 		$1.51M Buy
10,724
+5,624
+110% +$829K 0.02% 632
2016
Q1 		$666K Buy
+5,100
New +$635K 0.01% 899

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Nisa Investment Advisors's JAZZ Position: Q1 2026 in Review

Nisa Investment Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, buying an estimated $699 and bringing the position to 42 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Nisa Investment Advisors first reported a position in JAZZ in Q1 2016 and has held it in 41 quarters since. The position peaked at $8.18M in Q4 2020. 572 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Nisa Investment Advisors held 42 shares of Jazz Pharmaceuticals worth $7.94K as of Q1 2026.
  • Nisa Investment Advisors bought 4 Jazz Pharmaceuticals shares in Q1 2026, an estimated $699.
  • Jazz Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2320 holding.
  • Nisa Investment Advisors first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 41 quarters since.
  • Nisa Investment Advisors's Jazz Pharmaceuticals position peaked at $8.18M in Q4 2020.
  • 572 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.